# A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

> clinical trial · VERIFIED · 2026-08-12

Status: RECRUITING · Sponsor: Debiopharm International SA · Condition: Acute Myeloid Leukemia

- Company: Debiopharm International SA
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06969430

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.